Results 61 to 70 of about 1,218,098 (252)

The role of the right ventricle in pulmonary arterial hypertension [PDF]

, 2011
Although changes in the pulmonary vasculature are the primary cause of pulmonary arterial hypertension (PAH), severity of symptoms and survival are strongly associated with right ventricular function, and right heart failure is the main cause of death in
A. Vonk Noordegraaf, Vonk Noordegraaf, A., N. Galiè, Galie, N.   +3 more
core   +3 more sources

CXCR4 Inhibition Ameliorates Severe Obliterative Pulmonary Hypertension and Accumulation of C-Kit+ Cells in Rats [PDF]

, 2014
Successful curative treatment of severe pulmonary arterial hypertension with luminal obliteration will require a thorough understanding of the mechanism underlying the development and progression of pulmonary vascular lesions.
Alhussini, Aysar A., Voelkel, N.F., Alhussaini, A.A., Donatas Kraskauskas, Kraskauskiene, V., Daniela Farkas, Aysar A. Alhussaini (526867), Carlyne D. Cool (526869), Kraskauskas, Donatas, Cool, Carlyne D., Donatas Kraskauskas (289543), Cool, C.D., Bogaard, Harm J., Farkas, Daniela, Farkas, D., Norbert F Voelkel, Drake, Jennifer, Carlyne D Cool, Laszlo Farkas (91352), Norbert F. Voelkel (177151), Kraskauskiene, Vita, Jennifer I Drake, Aysar A Alhussaini, Drake, J.I., Bogaard, H.J., Voelkel, Norbert F., Jennifer I. Drake (526866), Farkas, L., Vita Kraskauskiene, Harm J. Bogaard (289545), Kraskauskas, D., Harm J Bogaard, Daniela Farkas (334698), Vita Kraskauskiene (526868), Laszlo Farkas, Farkas, Laszlo   +35 more
core   +1 more source

Primary Aldosteronism and Long‐Term Cardiovascular Complications: Comparison of Medical Versus Surgical Treatment

The Journal of Clinical Hypertension
The study aims to evaluate the long‐term incidence of cardiovascular events (CVE) and compare the effectiveness of medical and surgical interventions using a combined cardiovascular endpoint in individuals diagnosed with primary aldosteronism (PA).
Sofia Benameur, Julien Bertolino, Laura Bonnaud, Ngoc Anh Thu Nguyen, Barbara Leclercq, François Silhol, Frederic Castinetti, Frederic Sebag, Bernard Vaisse, Gabrielle Sarlon‐Bartoli   +9 more
doaj   +1 more source

Hipertensão arterial na gravidez: avaliação de um protocolo de tratamento Arterial hypertension in pregnancy: analysis of a manegement protocol [PDF]

, 2004
Dissertação (mestrado) - Universidade Federal de Santa Catarina. Centro de Ciências da Saúde. Programa de Pós-Graduação em Ciências Médicas.Introdução: A hipertensão arterial é a mais importante causa de morte materna no estado de Santa Catarina e nos ...
Jorge Abi Saab Neto, Saab Neto, Jorge Abi   +1 more
core   +1 more source

Pulmonary arterial hypertension: diagnosis and treatment

, 2013
Pulmonary arterial hypertension is one of the clinical groups of arterial hypertension. It is a rare, chronic disease with a very poor prognosis.
Agnieszka Łętek, Grzegorz Raczyński, Agnieszka Janion-Sadowska, Marcin Sadowski, Łukasz Zandecki   +4 more
core   +1 more source

Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. [PDF]

, 2013
Survival in patients with pulmonary arterial hypertension (PAH) is closely related to right ventricular (RV) function. Although pulmonary load is an important determinant of RV systolic function in PAH, there remains a significant variability in RV ...
Voelkel, N.F., Kawut, Steven M, Forfia, Paul R, Voelkel, Norbert F, Provencher, Steve, Oudiz, Ronald J, Haddad, F., Kawut, S.M., Newman, J., Kawut, Steven M., Naeije, R., Hassoun, P.M., Chin, Kelly M, Lumens, Joost, Forfia, Paul R., Newman, John, Voelkel, Norbert F., Forfia, P.R., Vonk-Noordegraaf, Anton, Lumens, Joost; id_orcid, Oudiz, Ronald J., Chin, K.M., Hassoun, Paul M, Torbicki, Adam, Oudiz, R.J., Hassoun, Paul M., Vonk-Noordegraaf, A., Torbicki, A., Chin, Kelly M., Provencher, S., Lumens, J., Haddad, François, Naeije, Robert   +32 more
core   +1 more source

Hypertension [PDF]

, 2004
Hypertension is a rapidly moving clinical field with frequent developments in new pharmacologic agents and management strategies. Perhaps more importantly, there have been substantial improvements in our understanding of how best to use the drugs ...
Farrugia, Emanuel
core  

Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1):a randomised double-blind controlled trial [PDF]

, 2015
INTRODUCTION: Previous studies have suggested that more intensive initial therapy for hypertension results in better long-term blood pressure (BP) control.
Williams, B, Caulfield, M, MacDonald, TM, Cruickshank, JK, MacDonald, Thomas M, Ford, I, Morant, S, Sever, Peter, Webb, David J, Caulfield, Mark, Brown, MJ, McInnes, G, Salsbury, J, Cruickshank, J Kennedy, Williams, Bryan, MacDonald, Thomas M., McInnes, Gordon, Salsbury, Jackie, Morant, Steve, Mackenzie, IS, Mackenzie, Isla S, Mackenzie, Isla S.; id_orcid, Ford, Ian, Webb, DJ, Brown, Morris J., Cruickshank, J. Kennedy, Webb, David J., Brown, Morris, Sever, P   +28 more
core   +2 more sources

Cardiovascular regulation and vascular structure in prehypertension and coronary heart disease [PDF]

, 2009
The aim of this thesis was to characterize vascular structure and different aspects of cardiovascular regulation in otherwise healthy subjects with slightly elevated blood pressure and compare to healthy subjects with normotension and also investigate ...
Myredal, Anna
core   +1 more source

Tadalafil therapy for pulmonary arterial hypertension

, 2009
BACKGROUND: Treatment options for pulmonary arterial hypertension target the prostacyclin, endothelin, or nitric oxide pathways. Tadalafil, a phosphodiesterase type-5 inhibitor, increases cGMP, the final mediator in the nitric oxide pathway.
Frumkin, L., White, R. J., M. Chan, H. A. Ghofrani, L. Frumkin, B. H. Brundage, Beardsworth, A., Barst, R. J., A. Beardsworth, Galie, N., Z. Safdar, R. J. White, FEDELE, Francesco, Safdar, Z., G. Simonneau, Ghofrani, H. A., Shapiro, S., Simonneau, G., N. Galie, Oudiz, R. J., S. Shapiro, R. J. Oudiz, Chan, M., Brundage, B. H., T. O. Tadalafil Study Group: Response, Arterial Hypertension Pulmonary, R. J. Barst   +26 more
core   +1 more source